{"gene":"PIWIL3","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2020,"finding":"PIWIL3 localizes to mitochondria in bovine oocytes and forms a three-membered complex with TDRKH (Tudor and KH domain-containing protein) and PNLDC1 (poly(A)-specific ribonuclease-like domain containing 1); mutagenesis demonstrated that N-terminal arginines of PIWIL3 are required for complex assembly. The complex-bound piRNAs map ~50% to transposable elements, consistent with a genome-integrity role.","method":"Immunolocalization, co-immunoprecipitation, mutagenesis of N-terminal arginines, piRNA sequencing","journal":"Cells","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal Co-IP with mutagenesis validation and piRNA sequencing in a single rigorous study","pmids":["32486081"],"is_preprint":false},{"year":2017,"finding":"PIWIL3 was identified as a direct mechanistic target of enoxacin (a small-molecule RNAi activator) using a clickable enoxacin surrogate (alkenox) coupled with quantitative mass spectrometry; results suggest that cancer cells re-express PIWIL3 to repress RNAi through miRNAs.","method":"Click chemistry with clickable enoxacin surrogate (alkenox) coupled to quantitative mass spectrometry","journal":"Journal of the American Chemical Society","confidence":"Medium","confidence_rationale":"Tier 2 — chemical biology target-ID method with quantitative MS, single study","pmids":["28094937"],"is_preprint":false},{"year":2018,"finding":"PIWIL3 binds piR-30188 in glioma cells; the PIWIL3/piR-30188 complex targets OIP5-AS1 lncRNA (binding confirmed by RNA immunoprecipitation and luciferase assay), placing PIWIL3 upstream in a PIWIL3→piR-30188→OIP5-AS1→miR-367-3p→CEBPA feedback loop that regulates glioma cell growth; CEBPA was further shown to transcriptionally activate PIWIL3, closing the loop.","method":"RNA immunoprecipitation (RIP), luciferase reporter assay, siRNA knockdown, overexpression, in vivo xenograft","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2-3 — RIP and luciferase assays confirm binding, multiple pathway components validated, single lab","pmids":["29464001"],"is_preprint":false},{"year":2017,"finding":"Knockdown of PIWIL3 in gastric cancer cells suppresses proliferation, migration, and invasion, and downregulates metastasis-related genes (RhoC, MTA1, MMP2, MMP9) while modulating phosphorylation of JAK2 and STAT3, placing PIWIL3 upstream of the JAK2/STAT3 signaling pathway.","method":"siRNA knockdown, CCK-8 proliferation assay, invasion/migration assays, Western blotting for pathway phosphorylation, nude mouse xenograft","journal":"Cancer biomarkers","confidence":"Medium","confidence_rationale":"Tier 2-3 — clean KD with defined cellular phenotype and pathway phosphorylation readout, single lab","pmids":["28869440"],"is_preprint":false},{"year":2025,"finding":"In rabbit (a non-rodent mammal sharing high PIWIL3 homology with human), PIWIL3 knockout via CRISPR-Cas9 causes severe oogenesis defects and maternal-effect embryonic arrest at the 8-cell stage. Mechanistically, rabbit PIWIL3 binds ~18-nucleotide piRNAs (mirroring human PIWIL3), is critical for piRNA biogenesis, and acts as a dual regulator: silencing transposons during late oogenesis while activating another set during early embryogenesis, with broad regulation of transcriptomic and proteomic landscapes.","method":"CRISPR-Cas9 knockout in rabbit, small RNA sequencing (piRNA size and biogenesis), transcriptomics, proteomics, transposon expression analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1-2 — CRISPR KO with defined developmental phenotype and multiomics mechanistic follow-up; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2025.10.23.684072"],"is_preprint":true},{"year":2025,"finding":"In human oocytes, PIWIL3-associated short piRNAs (~18 nt) are the predominant small non-coding RNAs during oogenesis; their marked increase after the primordial follicle stage coincides with global downregulation of transposable element expression (particularly LINE-1 and ERVs), establishing PIWIL3-bound short piRNAs as the primary broad-spectrum suppressors of transposons in human female germ cells.","method":"Single-oocyte simultaneous small and long RNA sequencing across four developmental stages, genomic-context piRNA cluster analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multi-stage single-cell sequencing with genomic context analysis; preprint, single lab","pmids":["bio_10.1101_2025.07.22.666229"],"is_preprint":true},{"year":2008,"finding":"PIWIL3 protein was detected by immunohistochemistry in the cytoplasm of human astrocytic glioma and meningioma tumor tissues using specific polyclonal antibodies validated by ELISA and Western blot.","method":"Polyclonal antibody preparation, ELISA, Western blot, immunohistochemistry on tumor tissue biochips","journal":"Xi bao yu fen zi mian yi xue za zhi","confidence":"Low","confidence_rationale":"Tier 3 — localization only, no functional consequence demonstrated","pmids":["18616918"],"is_preprint":false}],"current_model":"PIWIL3 is an Argonaute/PIWI-subfamily protein that binds short (~18 nt) piRNAs in mammalian (including human) oocytes, where it forms a mitochondria-associated complex with TDRKH and PNLDC1 (requiring N-terminal arginines for assembly), drives piRNA biogenesis, and acts as a dual regulator that broadly silences transposable elements (LINE-1, ERVs) during oogenesis while modulating transposon activity and the transcriptome/proteome during early embryogenesis; in somatic cancer contexts it is a direct binding target of the RNAi-activating compound enoxacin and participates in a PIWIL3/piR-30188/OIP5-AS1/miR-367-3p/CEBPA feedback loop and JAK2/STAT3 signaling."},"narrative":{"teleology":[{"year":2008,"claim":"Initial detection of PIWIL3 protein in human tumor tissues established that this germ-line-associated PIWI protein is expressed in somatic cancers, raising the question of what functional role it plays outside the germline.","evidence":"Immunohistochemistry with validated polyclonal antibodies on human glioma and meningioma tissue biochips","pmids":["18616918"],"confidence":"Low","gaps":["No functional data; expression detection only without knockdown or mechanistic follow-up","Antibody specificity not confirmed by knockout control","No piRNA profiling performed"]},{"year":2017,"claim":"Two independent studies began to define PIWIL3's somatic functions: identification as a direct binding target of the RNAi-activating drug enoxacin suggested PIWIL3 modulates small RNA pathways in cancer cells, while knockdown in gastric cancer cells revealed PIWIL3 promotes proliferation, migration, and invasion upstream of JAK2/STAT3 phosphorylation.","evidence":"Click-chemistry/quantitative mass spectrometry target identification (enoxacin); siRNA knockdown with proliferation, invasion assays, and Western blot for JAK2/STAT3 phosphorylation in gastric cancer cells and xenografts","pmids":["28094937","28869440"],"confidence":"Medium","gaps":["Enoxacin binding site on PIWIL3 and downstream consequence not mapped","JAK2/STAT3 activation mechanism (direct vs. indirect) unresolved","No piRNA partner identified in gastric cancer context"]},{"year":2018,"claim":"The discovery that PIWIL3 binds piR-30188 to target the lncRNA OIP5-AS1, feeding into a miR-367-3p/CEBPA transcriptional feedback loop in glioma, provided the first piRNA-guided target-recognition mechanism for PIWIL3 in a somatic setting.","evidence":"RNA immunoprecipitation, luciferase reporter assays, siRNA/overexpression perturbations, and in vivo xenograft in glioma cells","pmids":["29464001"],"confidence":"Medium","gaps":["Direct cleavage of OIP5-AS1 by PIWIL3/piR-30188 not demonstrated biochemically","Feedback loop validated in a single glioma cell line","Relationship between this axis and JAK2/STAT3 signaling unknown"]},{"year":2020,"claim":"Demonstrating the native germline context, PIWIL3 was shown to localize to mitochondria in oocytes and assemble into a trimeric piRNA-processing complex with TDRKH and PNLDC1 via its N-terminal arginines, with ~50% of complex-bound piRNAs mapping to transposable elements—establishing the biochemical basis for its genome defense role.","evidence":"Co-immunoprecipitation, immunolocalization, N-terminal arginine mutagenesis, and piRNA sequencing in bovine oocytes","pmids":["32486081"],"confidence":"High","gaps":["Catalytic slicer activity of PIWIL3 in this complex not directly tested","Structural basis of TDRKH/PNLDC1 recognition of PIWIL3 N-terminal arginines unknown","Whether the same trimeric complex forms in human oocytes not shown"]},{"year":2025,"claim":"Genetic loss-of-function and single-oocyte profiling studies converged to establish PIWIL3 as essential for piRNA biogenesis, transposon silencing, and oocyte-to-embryo transition: rabbit CRISPR knockout caused oogenesis defects and 8-cell embryonic arrest with derepressed transposons, while human oocyte sequencing showed PIWIL3-bound ~18 nt piRNAs are the dominant small RNAs that suppress LINE-1 and ERVs during oogenesis.","evidence":"CRISPR-Cas9 knockout in rabbit with small RNA-seq, transcriptomics, proteomics (preprint); single-oocyte simultaneous small/long RNA sequencing across four human developmental stages (preprint)","pmids":["bio_10.1101_2025.10.23.684072","bio_10.1101_2025.07.22.666229"],"confidence":"Medium","gaps":["Both studies are preprints awaiting peer review","Human genetic loss-of-function data for PIWIL3 not yet available","Mechanism by which PIWIL3 switches from transposon repression to activation in early embryogenesis unclear"]},{"year":null,"claim":"Key unresolved questions include whether PIWIL3 possesses endonucleolytic slicer activity in vivo, how the PIWIL3/TDRKH/PNLDC1 complex coordinates piRNA 3′-end trimming, whether PIWIL3 loss in humans causes infertility, and the physiological relevance of PIWIL3 re-expression in somatic cancers.","evidence":"","pmids":[],"confidence":"Low","gaps":["No biochemical reconstitution of PIWIL3 slicer or piRNA-trimming activity","No human genetic study linking PIWIL3 mutations to reproductive phenotypes","Structural model of PIWIL3-piRNA complex absent"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,2,4,5]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0]}],"complexes":["PIWIL3/TDRKH/PNLDC1 piRNA-processing complex"],"partners":["TDRKH","PNLDC1"],"other_free_text":[]},"mechanistic_narrative":"PIWIL3 is an Argonaute/PIWI-subfamily protein that functions as a piRNA-guided regulator of transposable elements and gene expression during mammalian oogenesis and early embryogenesis. In oocytes, PIWIL3 binds ~18-nucleotide piRNAs—the predominant small non-coding RNA class in human female germ cells—and localizes to mitochondria as part of a trimeric complex with TDRKH and PNLDC1, whose assembly requires N-terminal arginines of PIWIL3 [PMID:32486081]. PIWIL3-bound piRNAs broadly suppress transposable elements (LINE-1, ERVs) during oogenesis, and CRISPR knockout in rabbit demonstrates that PIWIL3 is essential for piRNA biogenesis, transposon silencing, and maternal-effect progression past the 8-cell stage [PMID:bio_10.1101_2025.10.23.684072, PMID:bio_10.1101_2025.07.22.666229]. In somatic cancer contexts, PIWIL3 engages piRNA-mediated RNA targeting—binding piR-30188 to regulate the OIP5-AS1/miR-367-3p/CEBPA axis in glioma—and modulates JAK2/STAT3 signaling in gastric cancer cells [PMID:29464001, PMID:28869440]."},"prefetch_data":{"uniprot":{"accession":"Q7Z3Z3","full_name":"Piwi-like protein 3","aliases":[],"length_aa":882,"mass_kda":101.1,"function":"May play a role during spermatogenesis by repressing transposable elements and preventing their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Directly binds piRNAs, a class of 24 to 30 nucleotide RNAs that are generated by a Dicer-independent mechanism and are primarily derived from transposons and other repeated sequence elements. Besides their function in transposable elements repression, piRNAs are probably involved in other processes during meiosis such as translation regulation (By similarity)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q7Z3Z3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PIWIL3","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PIWIL3","total_profiled":1310},"omim":[{"mim_id":"610314","title":"PIWI-LIKE RNA-MEDIATED GENE SILENCING 3: PIWIL3","url":"https://www.omim.org/entry/610314"},{"mim_id":"609501","title":"TUDOR AND KH DOMAINS-CONTAINING PROTEIN; TDRKH","url":"https://www.omim.org/entry/609501"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytoplasmic bodies","reliability":"Approved"}],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PIWIL3"},"hgnc":{"alias_symbol":["HIWI3"],"prev_symbol":[]},"alphafold":{"accession":"Q7Z3Z3","domains":[{"cath_id":"3.30.70,3.30.70","chopping":"141-216","consensus_level":"medium","plddt":92.412,"start":141,"end":216},{"cath_id":"3.40.50.2300","chopping":"505-635","consensus_level":"high","plddt":91.8876,"start":505,"end":635}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z3Z3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z3Z3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z3Z3-F1-predicted_aligned_error_v6.png","plddt_mean":83.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PIWIL3","jax_strain_url":"https://www.jax.org/strain/search?query=PIWIL3"},"sequence":{"accession":"Q7Z3Z3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q7Z3Z3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q7Z3Z3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z3Z3"}},"corpus_meta":[{"pmid":"29464001","id":"PMC_29464001","title":"PIWIL3/OIP5-AS1/miR-367-3p/CEBPA feedback loop regulates the biological behavior of glioma cells.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/29464001","citation_count":117,"is_preprint":false},{"pmid":"28094937","id":"PMC_28094937","title":"Click Quantitative Mass Spectrometry Identifies PIWIL3 as a Mechanistic Target of RNA Interference Activator Enoxacin in Cancer Cells.","date":"2017","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/28094937","citation_count":22,"is_preprint":false},{"pmid":"28869440","id":"PMC_28869440","title":"Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer.","date":"2017","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/28869440","citation_count":21,"is_preprint":false},{"pmid":"32486081","id":"PMC_32486081","title":"PIWIL3 Forms a Complex with TDRKH in Mammalian Oocytes.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32486081","citation_count":14,"is_preprint":false},{"pmid":"27858163","id":"PMC_27858163","title":"Expression of PIWIL3 in primary and metastatic melanoma.","date":"2016","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27858163","citation_count":13,"is_preprint":false},{"pmid":"32357464","id":"PMC_32357464","title":"The Clinical Significance of PIWIL3 and PIWIL4 Expression in Pancreatic Cancer.","date":"2020","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32357464","citation_count":13,"is_preprint":false},{"pmid":"35117181","id":"PMC_35117181","title":"The expression and the role of PIWI like RNA-mediated gene silencing 3 (PIWIL3) in lung cell line.","date":"2020","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35117181","citation_count":2,"is_preprint":false},{"pmid":"18616918","id":"PMC_18616918","title":"[Preparation and distribution of polyclonal antibodies against human PIWIL3 protein in tumor tissues].","date":"2008","source":"Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18616918","citation_count":1,"is_preprint":false},{"pmid":"41751607","id":"PMC_41751607","title":"The Association Between Estrogen Receptor-α and PIWIL3/piR-651/piR-823 Complex Regulates MI to MII Transposition in Normoresponder and Diminished Ovarian Reserve Cases.","date":"2026","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/41751607","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.23.684072","title":"PIWIL3-piRNA Pathway Is Essential for Rabbit Oogenesis and Embryogenesis via Broad Regulation of the Transcriptome and Proteome","date":"2025-10-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.23.684072","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.22.666229","title":"Integrated small and long RNA sequencing in single oocytes reveals piRNA-mediated transposon repression during human oogenesis","date":"2025-07-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.22.666229","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6960,"output_tokens":1949,"usd":0.025057},"stage2":{"model":"claude-opus-4-6","input_tokens":5215,"output_tokens":4077,"usd":0.192},"total_usd":0.217057,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2020,\n      \"finding\": \"PIWIL3 localizes to mitochondria in bovine oocytes and forms a three-membered complex with TDRKH (Tudor and KH domain-containing protein) and PNLDC1 (poly(A)-specific ribonuclease-like domain containing 1); mutagenesis demonstrated that N-terminal arginines of PIWIL3 are required for complex assembly. The complex-bound piRNAs map ~50% to transposable elements, consistent with a genome-integrity role.\",\n      \"method\": \"Immunolocalization, co-immunoprecipitation, mutagenesis of N-terminal arginines, piRNA sequencing\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal Co-IP with mutagenesis validation and piRNA sequencing in a single rigorous study\",\n      \"pmids\": [\"32486081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PIWIL3 was identified as a direct mechanistic target of enoxacin (a small-molecule RNAi activator) using a clickable enoxacin surrogate (alkenox) coupled with quantitative mass spectrometry; results suggest that cancer cells re-express PIWIL3 to repress RNAi through miRNAs.\",\n      \"method\": \"Click chemistry with clickable enoxacin surrogate (alkenox) coupled to quantitative mass spectrometry\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — chemical biology target-ID method with quantitative MS, single study\",\n      \"pmids\": [\"28094937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PIWIL3 binds piR-30188 in glioma cells; the PIWIL3/piR-30188 complex targets OIP5-AS1 lncRNA (binding confirmed by RNA immunoprecipitation and luciferase assay), placing PIWIL3 upstream in a PIWIL3→piR-30188→OIP5-AS1→miR-367-3p→CEBPA feedback loop that regulates glioma cell growth; CEBPA was further shown to transcriptionally activate PIWIL3, closing the loop.\",\n      \"method\": \"RNA immunoprecipitation (RIP), luciferase reporter assay, siRNA knockdown, overexpression, in vivo xenograft\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — RIP and luciferase assays confirm binding, multiple pathway components validated, single lab\",\n      \"pmids\": [\"29464001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Knockdown of PIWIL3 in gastric cancer cells suppresses proliferation, migration, and invasion, and downregulates metastasis-related genes (RhoC, MTA1, MMP2, MMP9) while modulating phosphorylation of JAK2 and STAT3, placing PIWIL3 upstream of the JAK2/STAT3 signaling pathway.\",\n      \"method\": \"siRNA knockdown, CCK-8 proliferation assay, invasion/migration assays, Western blotting for pathway phosphorylation, nude mouse xenograft\",\n      \"journal\": \"Cancer biomarkers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — clean KD with defined cellular phenotype and pathway phosphorylation readout, single lab\",\n      \"pmids\": [\"28869440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In rabbit (a non-rodent mammal sharing high PIWIL3 homology with human), PIWIL3 knockout via CRISPR-Cas9 causes severe oogenesis defects and maternal-effect embryonic arrest at the 8-cell stage. Mechanistically, rabbit PIWIL3 binds ~18-nucleotide piRNAs (mirroring human PIWIL3), is critical for piRNA biogenesis, and acts as a dual regulator: silencing transposons during late oogenesis while activating another set during early embryogenesis, with broad regulation of transcriptomic and proteomic landscapes.\",\n      \"method\": \"CRISPR-Cas9 knockout in rabbit, small RNA sequencing (piRNA size and biogenesis), transcriptomics, proteomics, transposon expression analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — CRISPR KO with defined developmental phenotype and multiomics mechanistic follow-up; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.10.23.684072\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In human oocytes, PIWIL3-associated short piRNAs (~18 nt) are the predominant small non-coding RNAs during oogenesis; their marked increase after the primordial follicle stage coincides with global downregulation of transposable element expression (particularly LINE-1 and ERVs), establishing PIWIL3-bound short piRNAs as the primary broad-spectrum suppressors of transposons in human female germ cells.\",\n      \"method\": \"Single-oocyte simultaneous small and long RNA sequencing across four developmental stages, genomic-context piRNA cluster analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-stage single-cell sequencing with genomic context analysis; preprint, single lab\",\n      \"pmids\": [\"bio_10.1101_2025.07.22.666229\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PIWIL3 protein was detected by immunohistochemistry in the cytoplasm of human astrocytic glioma and meningioma tumor tissues using specific polyclonal antibodies validated by ELISA and Western blot.\",\n      \"method\": \"Polyclonal antibody preparation, ELISA, Western blot, immunohistochemistry on tumor tissue biochips\",\n      \"journal\": \"Xi bao yu fen zi mian yi xue za zhi\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization only, no functional consequence demonstrated\",\n      \"pmids\": [\"18616918\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PIWIL3 is an Argonaute/PIWI-subfamily protein that binds short (~18 nt) piRNAs in mammalian (including human) oocytes, where it forms a mitochondria-associated complex with TDRKH and PNLDC1 (requiring N-terminal arginines for assembly), drives piRNA biogenesis, and acts as a dual regulator that broadly silences transposable elements (LINE-1, ERVs) during oogenesis while modulating transposon activity and the transcriptome/proteome during early embryogenesis; in somatic cancer contexts it is a direct binding target of the RNAi-activating compound enoxacin and participates in a PIWIL3/piR-30188/OIP5-AS1/miR-367-3p/CEBPA feedback loop and JAK2/STAT3 signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PIWIL3 is an Argonaute/PIWI-subfamily protein that functions as a piRNA-guided regulator of transposable elements and gene expression during mammalian oogenesis and early embryogenesis. In oocytes, PIWIL3 binds ~18-nucleotide piRNAs—the predominant small non-coding RNA class in human female germ cells—and localizes to mitochondria as part of a trimeric complex with TDRKH and PNLDC1, whose assembly requires N-terminal arginines of PIWIL3 [PMID:32486081]. PIWIL3-bound piRNAs broadly suppress transposable elements (LINE-1, ERVs) during oogenesis, and CRISPR knockout in rabbit demonstrates that PIWIL3 is essential for piRNA biogenesis, transposon silencing, and maternal-effect progression past the 8-cell stage [PMID:bio_10.1101_2025.10.23.684072, PMID:bio_10.1101_2025.07.22.666229]. In somatic cancer contexts, PIWIL3 engages piRNA-mediated RNA targeting—binding piR-30188 to regulate the OIP5-AS1/miR-367-3p/CEBPA axis in glioma—and modulates JAK2/STAT3 signaling in gastric cancer cells [PMID:29464001, PMID:28869440].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Initial detection of PIWIL3 protein in human tumor tissues established that this germ-line-associated PIWI protein is expressed in somatic cancers, raising the question of what functional role it plays outside the germline.\",\n      \"evidence\": \"Immunohistochemistry with validated polyclonal antibodies on human glioma and meningioma tissue biochips\",\n      \"pmids\": [\"18616918\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional data; expression detection only without knockdown or mechanistic follow-up\", \"Antibody specificity not confirmed by knockout control\", \"No piRNA profiling performed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Two independent studies began to define PIWIL3's somatic functions: identification as a direct binding target of the RNAi-activating drug enoxacin suggested PIWIL3 modulates small RNA pathways in cancer cells, while knockdown in gastric cancer cells revealed PIWIL3 promotes proliferation, migration, and invasion upstream of JAK2/STAT3 phosphorylation.\",\n      \"evidence\": \"Click-chemistry/quantitative mass spectrometry target identification (enoxacin); siRNA knockdown with proliferation, invasion assays, and Western blot for JAK2/STAT3 phosphorylation in gastric cancer cells and xenografts\",\n      \"pmids\": [\"28094937\", \"28869440\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Enoxacin binding site on PIWIL3 and downstream consequence not mapped\", \"JAK2/STAT3 activation mechanism (direct vs. indirect) unresolved\", \"No piRNA partner identified in gastric cancer context\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The discovery that PIWIL3 binds piR-30188 to target the lncRNA OIP5-AS1, feeding into a miR-367-3p/CEBPA transcriptional feedback loop in glioma, provided the first piRNA-guided target-recognition mechanism for PIWIL3 in a somatic setting.\",\n      \"evidence\": \"RNA immunoprecipitation, luciferase reporter assays, siRNA/overexpression perturbations, and in vivo xenograft in glioma cells\",\n      \"pmids\": [\"29464001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct cleavage of OIP5-AS1 by PIWIL3/piR-30188 not demonstrated biochemically\", \"Feedback loop validated in a single glioma cell line\", \"Relationship between this axis and JAK2/STAT3 signaling unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating the native germline context, PIWIL3 was shown to localize to mitochondria in oocytes and assemble into a trimeric piRNA-processing complex with TDRKH and PNLDC1 via its N-terminal arginines, with ~50% of complex-bound piRNAs mapping to transposable elements—establishing the biochemical basis for its genome defense role.\",\n      \"evidence\": \"Co-immunoprecipitation, immunolocalization, N-terminal arginine mutagenesis, and piRNA sequencing in bovine oocytes\",\n      \"pmids\": [\"32486081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic slicer activity of PIWIL3 in this complex not directly tested\", \"Structural basis of TDRKH/PNLDC1 recognition of PIWIL3 N-terminal arginines unknown\", \"Whether the same trimeric complex forms in human oocytes not shown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Genetic loss-of-function and single-oocyte profiling studies converged to establish PIWIL3 as essential for piRNA biogenesis, transposon silencing, and oocyte-to-embryo transition: rabbit CRISPR knockout caused oogenesis defects and 8-cell embryonic arrest with derepressed transposons, while human oocyte sequencing showed PIWIL3-bound ~18 nt piRNAs are the dominant small RNAs that suppress LINE-1 and ERVs during oogenesis.\",\n      \"evidence\": \"CRISPR-Cas9 knockout in rabbit with small RNA-seq, transcriptomics, proteomics (preprint); single-oocyte simultaneous small/long RNA sequencing across four human developmental stages (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.10.23.684072\", \"bio_10.1101_2025.07.22.666229\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Both studies are preprints awaiting peer review\", \"Human genetic loss-of-function data for PIWIL3 not yet available\", \"Mechanism by which PIWIL3 switches from transposon repression to activation in early embryogenesis unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include whether PIWIL3 possesses endonucleolytic slicer activity in vivo, how the PIWIL3/TDRKH/PNLDC1 complex coordinates piRNA 3′-end trimming, whether PIWIL3 loss in humans causes infertility, and the physiological relevance of PIWIL3 re-expression in somatic cancers.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No biochemical reconstitution of PIWIL3 slicer or piRNA-trimming activity\", \"No human genetic study linking PIWIL3 mutations to reproductive phenotypes\", \"Structural model of PIWIL3-piRNA complex absent\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 2, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [\"PIWIL3/TDRKH/PNLDC1 piRNA-processing complex\"],\n    \"partners\": [\"TDRKH\", \"PNLDC1\"],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to correct the pathway section. The pathway should use Reactome term_ids, not GO terms. Let me fix this.\n\n```json\n{\n  \"mechanistic_narrative\": \"PIWIL3 is an Argonaute/PIWI-subfamily protein that functions as a piRNA-guided regulator of transposable elements and gene expression during mammalian oogenesis and early embryogenesis. In oocytes, PIWIL3 binds ~18-nucleotide piRNAs—the predominant small non-coding RNA class in human female germ cells—and localizes to mitochondria as part of a trimeric complex with TDRKH and PNLDC1, whose assembly requires N-terminal arginines of PIWIL3 [PMID:32486081]. PIWIL3-bound piRNAs broadly suppress transposable elements (LINE-1, ERVs) during oogenesis, and CRISPR knockout in rabbit demonstrates that PIWIL3 is essential for piRNA biogenesis, transposon silencing, and maternal-effect progression past the 8-cell stage [PMID:bio_10.1101_2025.10.23.684072, PMID:bio_10.1101_2025.07.22.666229]. In somatic cancer contexts, PIWIL3 engages piRNA-mediated RNA targeting—binding piR-30188 to regulate the OIP5-AS1/miR-367-3p/CEBPA axis in glioma—and modulates JAK2/STAT3 signaling in gastric cancer cells [PMID:29464001, PMID:28869440].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Initial detection of PIWIL3 protein in human tumor tissues established that this germ-line-associated PIWI protein is expressed in somatic cancers, raising the question of what functional role it plays outside the germline.\",\n      \"evidence\": \"Immunohistochemistry with validated polyclonal antibodies on human glioma and meningioma tissue biochips\",\n      \"pmids\": [\"18616918\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional data; expression detection only without knockdown or mechanistic follow-up\", \"Antibody specificity not confirmed by knockout control\", \"No piRNA profiling performed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Two independent studies began to define PIWIL3's somatic functions: identification as a direct binding target of the RNAi-activating drug enoxacin suggested PIWIL3 modulates small RNA pathways in cancer cells, while knockdown in gastric cancer cells revealed PIWIL3 promotes proliferation, migration, and invasion upstream of JAK2/STAT3 phosphorylation.\",\n      \"evidence\": \"Click-chemistry/quantitative mass spectrometry target identification (enoxacin); siRNA knockdown with proliferation, invasion assays, and Western blot for JAK2/STAT3 phosphorylation in gastric cancer cells and xenografts\",\n      \"pmids\": [\"28094937\", \"28869440\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Enoxacin binding site on PIWIL3 and downstream consequence not mapped\", \"JAK2/STAT3 activation mechanism (direct vs. indirect) unresolved\", \"No piRNA partner identified in gastric cancer context\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The discovery that PIWIL3 binds piR-30188 to target the lncRNA OIP5-AS1, feeding into a miR-367-3p/CEBPA transcriptional feedback loop in glioma, provided the first piRNA-guided target-recognition mechanism for PIWIL3 in a somatic setting.\",\n      \"evidence\": \"RNA immunoprecipitation, luciferase reporter assays, siRNA/overexpression perturbations, and in vivo xenograft in glioma cells\",\n      \"pmids\": [\"29464001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct cleavage of OIP5-AS1 by PIWIL3/piR-30188 not demonstrated biochemically\", \"Feedback loop validated in a single glioma cell line\", \"Relationship between this axis and JAK2/STAT3 signaling unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating the native germline context, PIWIL3 was shown to localize to mitochondria in oocytes and assemble into a trimeric piRNA-processing complex with TDRKH and PNLDC1 via its N-terminal arginines, with ~50% of complex-bound piRNAs mapping to transposable elements—establishing the biochemical basis for its genome defense role.\",\n      \"evidence\": \"Co-immunoprecipitation, immunolocalization, N-terminal arginine mutagenesis, and piRNA sequencing in bovine oocytes\",\n      \"pmids\": [\"32486081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic slicer activity of PIWIL3 in this complex not directly tested\", \"Structural basis of TDRKH/PNLDC1 recognition of PIWIL3 N-terminal arginines unknown\", \"Whether the same trimeric complex forms in human oocytes not shown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Genetic loss-of-function and single-oocyte profiling studies converged to establish PIWIL3 as essential for piRNA biogenesis, transposon silencing, and the oocyte-to-embryo transition: rabbit CRISPR knockout caused oogenesis defects and 8-cell embryonic arrest with derepressed transposons, while human oocyte sequencing showed PIWIL3-bound ~18 nt piRNAs are the dominant small RNAs that suppress LINE-1 and ERVs during oogenesis.\",\n      \"evidence\": \"CRISPR-Cas9 knockout in rabbit with small RNA-seq, transcriptomics, proteomics (preprint); single-oocyte simultaneous small/long RNA sequencing across four human developmental stages (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.10.23.684072\", \"bio_10.1101_2025.07.22.666229\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Both studies are preprints awaiting peer review\", \"Human genetic loss-of-function data for PIWIL3 not yet available\", \"Mechanism by which PIWIL3 switches from transposon repression to activation in early embryogenesis unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include whether PIWIL3 possesses endonucleolytic slicer activity in vivo, how the PIWIL3/TDRKH/PNLDC1 complex coordinates piRNA 3′-end trimming, whether PIWIL3 loss in humans causes infertility, and the physiological relevance of PIWIL3 re-expression in somatic cancers.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No biochemical reconstitution of PIWIL3 slicer or piRNA-trimming activity\", \"No human genetic study linking PIWIL3 mutations to reproductive phenotypes\", \"Structural model of PIWIL3-piRNA complex absent\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 2, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 4, 5]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"complexes\": [\"PIWIL3/TDRKH/PNLDC1 piRNA-processing complex\"],\n    \"partners\": [\"TDRKH\", \"PNLDC1\"],\n    \"other_free_text\": []\n  }\n}\n```"}